REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 5th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 30, 2022, by and among Orgenesis Inc., a Nevada corporation (the “Company”), and the investors signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • April 5th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 30, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 5th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (“Agreement”) is made as of March 30, 2022 (the “Effective Date”), by and among Orgenesis Inc., a Nevada corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Exhibit A hereto (the “Schedule of Purchasers”). Such persons and entities are hereinafter collectively referred to herein as “Purchasers” and each individually as a “Purchaser.”
